Position in TNXP
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$2,499,160
-$3,945,629 QoQ
Shares Held
195,859
-58.2% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 103 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNXP Over Time
Shares Held
Position Value (USD)
Derivatives in TNXP
reported options exposure · as of Jun 30, 2026CallValue
$586,960
CallShares
46,000
PutValue
$576,752
PutShares
45,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. TNXP ranks #189 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in TNXP
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $586,960 | 46,000 | Call | Defined | 2026-09-02 | |
| 2026-06-30 | $2,499,160 | 195,859 | Shares | Defined | 2026-09-02 | |
| 2026-06-30 | $576,752 | 45,200 | Put | Defined | 2026-09-02 | |
| 2026-03-31 | $239,250 | 17,400 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $6,444,789 | 468,712 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $353,375 | 25,700 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $621,676 | 39,800 | Put | Defined | 2026-02-17 | |
| 2025-06-30 | $254,630 | 7,077 | Shares | Defined | 2025-08-14 | |
| 2022-09-30 | $13,863 | 26,159 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $93,057 | 58,897 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $53,481 | 232,528 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $79,021 | 219,505 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $373,306 | 622,178 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $775,921 | 606,189 | Shares | Defined | 2021-05-21 | |
| 2020-09-30 | $66,521 | 79,192 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $270,114 | 442,811 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $59,618 | 83,970 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||